// App-Quantinova.ai

4348 : Cluster analysis of cardiovascular risk phenotypes in patients with type 2 diabetes and established atherosclerotic cardiovascular disease: a potential approach to precision medicine

Researchers

Presenter

  • A Sharma

Principal Investigators

  • Y Zheng

  • J A Ezekowitz

  • C M Westerhout

  • S G Goodman

  • P W Armstrong

  • J B Buse

  • J B Green

  • K D Kaufman

  • D K McGuire

Medical Centers

  • Duke Clinical Research Institute - Durham - United States of America

  • Canadian Vigour Center, Edmonton, Canada

  • Mazankowski Alberta Heart Institute, Edmonton, AB, Canada

  • University of North Carolina Hospitals, Chapel Hill, United States of America

  • Merck, Sharp & Dohme Corp., Kenilworth, United States of America

  • University of Texas Southwestern Medical School, Dallas, United States of America

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sitagliptin

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved